Castleview Partners, LLC Astrazeneca PLC Transaction History

Castleview Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$66.81 - $80.83 $1,737 - $2,101	26 Added 72.22%	62 $4,000
Q1 2024 May 09, 2024	SELL	$61.03 - $69.57 $16,295 - $18,575	-267 Reduced 88.12%	36 $2,000
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $838 - $909	-12 Reduced 3.81%	303 $21,000
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $19,892 - $22,554	315 New	315 $21,000
Q3 2022 Nov 10, 2022	SELL	$53.02 - $135.75 $174,276 - $446,210	-3,287 Reduced 91.31%	313 $17,000
Q2 2022 Aug 17, 2022	SELL	$59.26 - $71.14 $1.01 Million - $1.22 Million	-17,079 Reduced 82.59%	3,600 $237,000
Q2 2022 Aug 16, 2022	BUY	$59.26 - $71.14 $1.19 Million - $1.43 Million	20,105 Added 3502.61%	20,679 $1.37 Million
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $117,290 - $141,287	-2,105 Reduced 78.57%	574 $38,000
Q4 2021 Feb 17, 2022	BUY	$54.02 - $63.83 $141,694 - $167,426	2,623 Added 4683.93%	2,679 $156,000
Q2 2021 Aug 17, 2021	BUY	$48.42 - $60.18 $2,711 - $3,370	56 New	56 $3,000

1,343

492M

4.99M

3.19M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $233B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Castleview Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Castleview Partners, LLC with notifications on news.